{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:52:37Z","timestamp":1794718357629,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["82403164"],"award-info":[{"award-number":["82403164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["82073172"],"award-info":[{"award-number":["82073172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["81572546"],"award-info":[{"award-number":["81572546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune tolerance in epithelial ovarian cancer (EOC) enables cancer cells to evade immune surveillance. Myeloid-derived suppressor cells (MDSCs), as crucial immunosuppressive regulators, shape the tumor microenvironment and contribute to resistance against immunotherapy. However, the regulatory mechanisms of MDSCs in ovarian cancer remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined the presence and distribution of MDSCs in peripheral blood and tumor tissues from EOC patients. Transcriptomic analysis was performed on ovarian cancer cells co-cultured with MDSCs. The role of Serum Amyloid A1 (SAA1) was investigated through in vitro functional assays, co-culture experiments, and in vivo mouse models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MDSCs were enriched in both peripheral blood and tumor tissues of EOC patients. SAA1 was significantly upregulated in ovarian cancer cells after interaction with MDSCs and confirmed in tumor samples and cell lines. Functionally, SAA1 promoted cancer cell proliferation, migration, and invasion. It also recruited MDSCs via TLR2\/4, induced the differentiation of granulocyte-monocyte progenitors (GMPs), and stimulated IL-1\u03b2 secretion, which in turn enhanced SAA1 expression, forming a positive feedback loop. In vivo, SAA1 promoted tumor progression and ascites formation. Clinically, high levels of SAA1, IL-1\u03b2, and CD33\u207a MDSCs correlated with poor survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study uncovers a novel SAA1\u2013IL-1\u03b2 feedback loop that promotes immunosuppression and progression in ovarian cancer. These findings provide insight into tumor\u2013immune interactions and suggest a potential biomarker and therapeutic target for EOC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03536-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:40:44Z","timestamp":1759236044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tumor cells promote immunosuppression in ovarian cancer via a positive feedback loop with MDSCs through the SAA1\u2013IL-1\u03b2 axis"],"prefix":"10.1186","volume":"44","author":[{"given":"Haoran","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilale","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"3","key":"3536_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3536_CR2","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"3536_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","volume":"28","author":"A Malpica","year":"2004","unstructured":"Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28(4):496\u2013504.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3536_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jamaoncol.2018.6258","volume":"5","author":"ML Disis","year":"2019","unstructured":"Disis ML, Taylor MH, Kelly K, Beck JT, Gordon M, Moore KM, et al. Efficacy and safety of avelumab for patients with recurrent or refractory ovarian cancer: phase 1b results from the JAVELIN solid tumor trial. JAMA Oncol. 2019;5(3):393\u2013401.","journal-title":"JAMA Oncol"},{"key":"3536_CR5","doi-asserted-by":"publisher","first-page":"604084","DOI":"10.3389\/fonc.2020.604084","volume":"10","author":"F Ning","year":"2020","unstructured":"Ning F, Cole CB, Annunziata CM. Driving immune responses in the ovarian tumor microenvironment. Front Oncol. 2020;10:604084.","journal-title":"Front Oncol"},{"issue":"1","key":"3536_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","volume":"40","author":"RJ Tesi","year":"2019","unstructured":"Tesi RJ. MDSC; the most important cell you have never heard of. Trends Pharmacol Sci. 2019;40(1):4\u20137.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"3536_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde S, Leader AM, Merad M. MDSC: markers, development, states, and unaddressed complexity. Immunity. 2021;54(5):875\u201384.","journal-title":"Immunity"},{"issue":"3","key":"3536_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","volume":"41","author":"L van Vlerken-Ysla","year":"2023","unstructured":"van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI. Functional States of myeloid cells in cancer. Cancer Cell. 2023;41(3):490\u2013504.","journal-title":"Cancer Cell"},{"issue":"1","key":"3536_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","volume":"120","author":"C Groth","year":"2019","unstructured":"Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120(1):16\u201325.","journal-title":"Br J Cancer"},{"key":"3536_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3389\/fimmu.2019.00949","volume":"10","author":"FM Consonni","year":"2019","unstructured":"Consonni FM, Porta C, Marino A, Pandolfo C, Mola S, Bleve A, et al. Myeloid-Derived suppressor cells: ductile targets in disease. Front Immunol. 2019;10:949.","journal-title":"Front Immunol"},{"key":"3536_CR11","doi-asserted-by":"crossref","unstructured":"Lim HX, Kim TS, Poh CL. Understanding the differentiation, expansion, recruitment and suppressive activities of Myeloid-Derived suppressor cells in cancers. Int J Mol Sci 2020, 21(10).","DOI":"10.3390\/ijms21103599"},{"issue":"44","key":"3536_CR12","doi-asserted-by":"publisher","first-page":"76843","DOI":"10.18632\/oncotarget.20164","volume":"8","author":"L Wu","year":"2017","unstructured":"Wu L, Deng Z, Peng Y, Han L, Liu J, Wang L, et al. Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-\/low) myeloid-derived suppressor cells in ovarian cancer patients. Oncotarget. 2017;8(44):76843\u201356.","journal-title":"Oncotarget"},{"issue":"1","key":"3536_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41467-018-03966-7","volume":"9","author":"M Taki","year":"2018","unstructured":"Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, et al. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation. Nat Commun. 2018;9(1):1685.","journal-title":"Nat Commun"},{"issue":"13","key":"3536_CR14","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1158\/0008-5472.CAN-16-3199","volume":"77","author":"D Wang","year":"2017","unstructured":"Wang D, Sun H, Wei J, Cen B, DuBois RN. CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer. Cancer Res. 2017;77(13):3655\u201365.","journal-title":"Cancer Res"},{"key":"3536_CR15","doi-asserted-by":"crossref","unstructured":"Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S et al. Cancer-Associated fibroblasts neutralize the Anti-tumor effect of CSF1 receptor Blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell 2017, 32(5): 654\u2013e668655.","DOI":"10.1016\/j.ccell.2017.10.005"},{"issue":"1","key":"3536_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","volume":"24","author":"GH Sack","year":"2018","unstructured":"Sack GH. Jr. Serum amyloid A - a review. Mol Med. 2018;24(1):46.","journal-title":"Mol Med"},{"issue":"1","key":"3536_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","volume":"180","author":"JY Lee","year":"2020","unstructured":"Lee JY, Hall JA, Kroehling L, Wu L, Najar T, Nguyen HH, et al. Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell. 2020;180(1):79\u2013e9116.","journal-title":"Cell"},{"key":"3536_CR18","doi-asserted-by":"crossref","unstructured":"Zhao Y, Chen Y, Wan Q, Xiao C, Guo Z, Du X et al. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment. J Cancer Res Clin Oncol 2023.","DOI":"10.1007\/s00432-023-05296-8"},{"issue":"3","key":"3536_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1021\/pr101154j","volume":"10","author":"HJ Sung","year":"2011","unstructured":"Sung HJ, Ahn JM, Yoon YH, Rhim TY, Park CS, Park JY, et al. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. J Proteome Res. 2011;10(3):1383\u201395.","journal-title":"J Proteome Res"},{"issue":"1","key":"3536_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bjc.6605720","volume":"103","author":"SL Wood","year":"2010","unstructured":"Wood SL, Rogers M, Cairns DA, Paul A, Thompson D, Vasudev NS, et al. Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer. Br J Cancer. 2010;103(1):101\u201311.","journal-title":"Br J Cancer"},{"issue":"4","key":"3536_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/cncr.24838","volume":"116","author":"E Cocco","year":"2010","unstructured":"Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Buza N, Tavassoli FA, et al. Serum amyloid A: a novel biomarker for endometrial cancer. Cancer. 2010;116(4):843\u201351.","journal-title":"Cancer"},{"issue":"2","key":"3536_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.bjc.6605129","volume":"101","author":"E Cocco","year":"2009","unstructured":"Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Casagrande F, Buza N, et al. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. Br J Cancer. 2009;101(2):335\u201341.","journal-title":"Br J Cancer"},{"issue":"13","key":"3536_CR23","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1200\/JCO.2008.18.0554","volume":"27","author":"P Findeisen","year":"2009","unstructured":"Findeisen P, Zapatka M, Peccerella T, Matzk H, Neumaier M, Schadendorf D, et al. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. J Clin Oncol. 2009;27(13):2199\u2013208.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3536_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11060-017-2386-z","volume":"132","author":"FH Knebel","year":"2017","unstructured":"Knebel FH, Uno M, Galatro TF, Bell\u00e9 LP, Oba-Shinjo SM, Marie SKN, et al. Serum amyloid A1 is upregulated in human glioblastoma. J Neurooncol. 2017;132(3):383\u201391.","journal-title":"J Neurooncol"},{"issue":"7747","key":"3536_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","volume":"567","author":"JW Lee","year":"2019","unstructured":"Lee JW, Stone ML, Porrett PM, Thomas SK, Komar CA, Li JH, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567(7747):249\u201352.","journal-title":"Nature"},{"key":"3536_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cytogfr.2015.12.010","volume":"30","author":"M De Buck","year":"2016","unstructured":"De Buck M, Gouwy M, Wang JM, Van Snick J, Proost P, Struyf S, et al. The cytokine-serum amyloid A-chemokine network. Cytokine Growth Factor Rev. 2016;30:55\u201369.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"3536_CR27","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3536_CR28","first-page":"280","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"3536_CR29","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1172\/JCI80006","volume":"125","author":"S Ugel","year":"2015","unstructured":"Ugel S, De Sanctis F, Mandruzzato S, Bronte V. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells Meet tumor-associated macrophages. J Clin Invest. 2015;125(9):3365\u201376.","journal-title":"J Clin Invest"},{"issue":"2","key":"3536_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19(2):108\u201319.","journal-title":"Nat Immunol"},{"key":"3536_CR31","doi-asserted-by":"crossref","unstructured":"Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, Lehti K. Fibroblasts in the tumor microenvironment: shield or spear?? Int J Mol Sci 2018, 19(5).","DOI":"10.3390\/ijms19051532"},{"issue":"10","key":"3536_CR32","doi-asserted-by":"publisher","first-page":"e0164514","DOI":"10.1371\/journal.pone.0164514","volume":"11","author":"S Zhang","year":"2016","unstructured":"Zhang S, Ma X, Zhu C, Liu L, Wang G, Yuan X. The role of Myeloid-Derived suppressor cells in patients with solid tumors: A Meta-Analysis. PLoS ONE. 2016;11(10):e0164514.","journal-title":"PLoS ONE"},{"issue":"1","key":"3536_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer. 2022;21(1):184.","journal-title":"Mol Cancer"},{"issue":"2","key":"3536_CR34","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3892\/ol.2017.6305","volume":"14","author":"K Gonda","year":"2017","unstructured":"Gonda K, Shibata M, Ohtake T, Matsumoto Y, Tachibana K, Abe N, et al. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncol Lett. 2017;14(2):1766\u201374.","journal-title":"Oncol Lett"},{"issue":"1","key":"3536_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbcan.2018.10.003","volume":"1871","author":"E Tulchinsky","year":"2019","unstructured":"Tulchinsky E, Demidov O, Kriajevska M, Barlev NA, Imyanitov E. EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer. Biochim Biophys Acta Rev Cancer. 2019;1871(1):29\u201339.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"3536_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated MicroRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond). 2021;41(3):199\u2013217.","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"3536_CR37","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/cas.14866","volume":"112","author":"H Ren","year":"2021","unstructured":"Ren H, He G, Lu Z, He Q, Li S, Huang Z, et al. Arecoline induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression. Cancer Sci. 2021;112(6):2173\u201384.","journal-title":"Cancer Sci"},{"issue":"1","key":"3536_CR38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3536_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41590-021-00967-5","volume":"22","author":"S Hangai","year":"2021","unstructured":"Hangai S, Kawamura T, Kimura Y, Chang CY, Hibino S, Yamamoto D, et al. Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells. Nat Immunol. 2021;22(8):947\u201357.","journal-title":"Nat Immunol"},{"issue":"2","key":"3536_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41423-020-00587-3","volume":"18","author":"K Rui","year":"2021","unstructured":"Rui K, Hong Y, Zhu Q, Shi X, Xiao F, Fu H, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine sj\u00f6gren\u2019s syndrome by modulating the function of myeloid-derived suppressor cells. Cell Mol Immunol. 2021;18(2):440\u201351.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3536_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12964-024-01771-y","volume":"22","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen Y, Pan X, Li P, Ren Z, Wang X, et al. IL-1\u03b2 mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer. Cell Commun Signal. 2024;22(1):408.","journal-title":"Cell Commun Signal"},{"key":"3536_CR42","doi-asserted-by":"crossref","unstructured":"Yang D, Sun X, Wang H, Wistuba II, Wang H, Maitra A, et al. TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1b(+) macrophages. Gastroenterology; 2025.","DOI":"10.1053\/j.gastro.2025.01.244"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03536-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:40:56Z","timestamp":1759236056000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03536-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3536"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03536-y","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical experiments in this study were approved by the Ethics Committee of the Shanghai First Maternity and Infant Hospital (approval number KS2326). All the included patients signed an informed consent form. All animal care and experiments were approved by the Animal Care Committee of Tongji University (approval number TJBA05723101).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}